Journal of Chinese Pharmaceutical Sciences ›› 2024, Vol. 33 ›› Issue (10): 918-931.DOI: 10.5246/jcps.2024.10.066
• Original articles • Previous Articles Next Articles
Xiaodan Wang1,2, Qinqing Li1,2, Wanwei Gui1,2, Dongyan Wu1,2, Jinmiao Chai1,2,*(), Wenbin He1,2, Junlong Zhang1,2,*()
Received:
2024-03-12
Revised:
2024-04-15
Accepted:
2024-06-23
Online:
2024-10-31
Published:
2024-10-31
Contact:
Jinmiao Chai, Junlong Zhang
Supported by:
Supporting:
Xiaodan Wang, Qinqing Li, Wanwei Gui, Dongyan Wu, Jinmiao Chai, Wenbin He, Junlong Zhang. Investigation of the apoptotic mechanism in hippocampal and retinal neurons of db/db mice induced by Dihuangyinzi decoction[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(10): 918-931.
[1] |
Chinese Elderly Type Diabetes Prevention and Treatment of Clinical Guidelines Writing Group, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society, Geriatric Professional Committee of Beijing Medical Award Foundation, National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital). Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition). Chin. J. Intern. Med. 2022, 61, 12–50.
|
Chinese Elderly Type Diabetes Prevention and Treatment of Clinical Guidelines Writing Group, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society, Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society, Geriatric Professional Committee of Beijing Medical Award Foundation, National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital). Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition). Chin. J. Intern. Med. 2022, 61, 12–50.
|
|
[2] |
Yang, S.H. TCM symptomatic classification and clinical study of cognitive impairment of type 2 diabetes mellitus. Chengdu Univ. Tradit. Chin. Med. 2017.
|
[3] |
Pan, X.L.; Pei, J.P.; Wang, A.X.; Shuai, W.; Feng, L.; Bu, F.Q.; Zhu, Y.M.; Zhang, L.; Wang, G.; Ouyang, L. Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy. Acta Pharm. Sin. B. 2022, 12, 2171–2192
|
[4] |
Zhang, N.; Wang, L.; Ma, T.; Chen, Z.G.; Li, N.N. Effect of DihuangYinzi on cognitive function in patients with mild Alzheimer’s disease. China Med. Herald. 2019, 16, 69–72.
|
[5] |
Lee, J.Y.; Kim, J.Y.; Lee, J.Y.; Jung, J.H.; Jung, I.C. Efficacy of Jihwangeumja (Dihuang Yinzi) on cognitive function and activities of daily living in patients with Alzheimer disease. Medicine. 2021, 100, e25592.
|
[6] |
Yan, J.L.; Tian, Y.J.; Han, C.; Qin, Y.L.; He, W.B.; Zhang, J.L. The co-syndrome mechanism of Alzheimer’s disease and Parkinson’s disease based on abnormal glucose metabolism. Chin. J. Gerontol. 2021, 41, 3861–3865.
|
[7] |
Wu, D.Y.; Wang, X.D.; Chai, J.M.; Li, Q.Q.; Li,Y.; Bi, M.; Gui, W.W.; Cao, H.M. Study on the mechanism of Danggui Buxue Decoction in the treatment of diabetic retinopathy based on network pharmacology and experiment. J. Chin. Pharm. Sci. 2023, 32, 527.
|
[8] |
Zimmet, P.; Shi, Z.M.; El-Osta, A.; Ji, L.N. Epidemic T2DM, early development and epigenetics: implications of the Chinese Famine. Nat. Rev. Endocrinol. 2018, 14, 738–746.
|
[9] |
Zimmet, P.Z.; Magliano, D.J.; Herman, W.H.; Shaw, J.E. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014, 2, 56–64.
|
[10] |
International Diabetes Federation. IDF Diabetes Atlas—8th edition. Diabetes Atlas http://diabetesatlas.org/resources/ 2017-atlas.html.
|
[11] |
Xue, M.; Xu, W.; Ou, Y.N.; Cao, X.P.; Tan, M.S.; Tan, L.; Yu, J.T. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res. Rev. 2019, 55, 100944.
|
[12] |
Li, H.M.; Ren, J.; Li, Y.S.; Wu, Q.; Wei, J.P. Oxidative stress: the nexus of obesity and cognitive dysfunction in diabetes. Front. Endocrinol. 2023, 14, 1134025.
|
[13] |
Wong, T.Y.; Sabanayagam, C. Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence. Ophthalmologica. 2020, 243, 9–20.
|
[14] |
Jia, L.N.; Wu, M.N.; Yin, C.H. Research progress on the pathogenesis of cognitive dysfunction in type 2 diabetes mellitus. Clin. Focus. 2023, 38, 554–558.
|
[15] |
Luo, A.L.; Xie, Z.; Wang, Y.; Wang, X.; Li, S.; Yan, J.; Zhan, G.F.; Zhou, Z.Q.; Zhao, Y.L.; Li, S.Y. Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies. Neurosci. Biobehav. Rev. 2022, 137, 104642.
|
[16] |
Huang, H.L. Clinical observation on the treatment of type 2 diabetes mellitus with yin and yang deficiency by adding and subtracting Dihuangyinzi. J. Practical. Diabetol.2018, 14, 37–38.
|
[17] |
Li, Q.; Jia, S.T.; Guan, H.B. Clinical effect observation of Dihuangyinzi in adjuvant treatment of deficiency of kidney and marrow syndrome type 2 diabetes mellitus with mild cognitive impairment. Lishizhen Med. Mater. Med. Res. 2022, 33, 410–412.
|
[18] |
Du, Y.K.; Xiao, Y.; Zhong, S.M.; Huang, Y.X.; Chen, Q.Q.; Zhou, Y.Q.; Guo, J.; Yang, C. Study on the mechanism of acori graminei rhizoma in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking. Chin. J. Gerontol. 2021, 43, 2913–2920.
|
[19] |
Han, R.; Ma, T.; Zhang, Z.C.; Gao, K.; Gao, J.F.; Tang, X.; Wen, B.Y.; Yan, Y. Experimental Research Progress of DihuangYinzi in Treatment of Alzheimer’s Disease. Chin. J. Exp. Tradit. Med. Form. 2018, 24, 124–130.
|
[20] |
Wang, B.Y.; Zhang, S.S. Research progress of traditional Chinese and western medicine in the intervention of prediabetes. Chin. Med. Mod. Distance Educ. China. 2023, 21, 205–208.
|
[21] |
Zhou, B.; Li, J.; Fang, C.; Huang, Y.; Sang, G.; Tao, S.; He, C. Comparison of therapeutic effect of metformin hydrochloride/vildagliptin and liraglutide on type 2 diabetes mellitus in obese patients. J. Southern Med. Univ. 2023, 43, 436–442.
|
[22] |
Hua, X.; Meng, L.; Meng, Z.R.; Wang, L.L.; Jia, L.; Gao, X.M.; Wang, J.Q. Medication Rules and Targets of Chinese Patent Medicines for Treating Type 2 Diabetes. World Chin. Med. 2023, 18, 692–698, 703.
|
[23] |
Tang, T.; Wei, L.Y.; Huang, J.M.; Tang, Q.L. Research progress on the mechanism of Bcl-2 protein family regulating apoptosis and its application in wound repair. Chongqing Med. 2023 , 52, 2854–2858.
|
[24] |
Xie, F.; Zhou, L. Effect of Modified DihuangYinzi Decoction on ethology and synaptic plasticity-relatedproteins in APP/PS1 double transgenic dementia mice. J. Qiqihar Med. Univ. 2023 , 44, 1101–1106.
|
[25] |
Zhuang, H.R.; Wu, Z.D.; Chen, X.H.; Li, C.J. Repair of diabetic retinopathy in rats by ShuoluoDite and its regulatory effects on the MAPK pathway. J. Anat. 2023, 54, 392–399.
|
[26] |
Li, C. GLCCI1’s Impact on Retinal Neurodegeneration in Diabetic Mice via JNK and Mechanistic Research. Jinzhou Med. Univ. 2023.
|
[27] |
Dong, Z.J.; Chen, Z.H.; Tao, X.Y.; Yu, H.F.; Yang, F. Silk gum inhibits retinal neurocyte apoptosis in diabetic rats by regulating the JNK signaling pathway. Hebei Med. J. 2018, 24, 794–797.
|
[28] |
Wang, W.H.; Wang, H.F. Electroacupuncture improves cognitive impairment in a diabetic mouse model by regulating hippocampal IRE1α-JNK pathway-related proteins. Acupunct. Res. 2022, 47, 1068–1072, 1079.
|
[29] |
Huang, C.; Zhu, H.J.; Li, H.; Li, Q.X.; Li, F.M.; Cheng, L.; Liu, Y.G. p38-MAPK pathway is activated in retinopathy of microvascular disease of STZ-induced diabetic rat model. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 5789–5796.
|
[30] |
Yuan, A.H.; Cao, J.P.; Yang, J.; Song, X.G.; Zha, B.X.; Gao, Z.Q.; Ye, M. Electroacupuncture inhibits the generation of pro-inflammatory cytokines in rats with DCI through the p38 MAPK and STAT3 signaling pathways, improving learning and memory. Acupunct. Res. 2020, 45, 603–610.
|
[1] | Hao Wang, Kangxue Chen, Yuyan Zhang, Kuijun Jiang, Zhonglei Sun. Developmental endothelial locus-1 enhances ER calmodulin expression, mitigates ER stress, suppresses inflammation, and attenuates neuronal apoptosis [J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(9): 795-804. |
[2] | Zhengru Han, Wanci Song, Yang Luo, Min Xiao, Mengheng Wang, Wuyinxiao Zheng, Hanxiong Dan, Qiang Yin, Hailong Yin, Pengtao You. Hugan Buzure granule ameliorates immune liver injury through the EGFR/Ras/PI3K/AKT signaling pathway: A network pharmacology study and experimental validation [J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(2): 123-141. |
[3] | Fan Wang, Ruili Li, Wenjun Wang, Xiaoyan Zhou, Meiyou Liu, Jinyi Zhao, Aidong Wen, Jingwen Wang, Yanyan Jia. α-Boswellic acid ameliorates acute kidney injury by inhibiting the TLR4-mediated inflammatory pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 539-550. |
[4] | Limei Yang, Liman Wang, Xuhui Huang, Jie Zhuang. Warfarin affects the proliferation and apoptosis of lung cancer cells by regulating the Gas6/Axl/PI3K/Akt/NF-κB pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 190-199. |
[5] | Peijie Chen, Yuntian Zhang. PTP1B restrains the apoptosis of activated hepatic stellate cells (HSCs) induced by TRAIL during the resolution of liver fibrosis [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 867-880. |
[6] | Wuyinxiao Zheng, Haiping Li, Laichun Luo, Chunling Hu, Pengtao You. PI3K/AKT/mTOR pathway inhibition and miR-210-mediated suppression of Atg7 promote autophagy in TOPC-induced apoptosis of H1975 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 881-892. |
[7] | Ziyi Wang, Xiaoyan Liu, Yuanjun Zhu, Ye Liu, Pingping Zhang, Yinye Wang. The protective effect of W026B on global cerebral ischemia/reperfusion injury model in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(2): 108-116. |
[8] | Chunyang Han, Taotao Sun, Guangtai Fan, Yawei Liu, Cuiyan Liu. Protective effects of Polygonatum sibiricum against CCl4-induced acute liver injury in rats through oxidative stress and mitochondrial apoptotic pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(4): 306-318. |
[9] | Kexiang Gao, Xiaoyan Liu, Yuanjun Zhu, Ye Liu, Yinye Wang. The influence of B55γ on the neuroprotective effect of W026B in t-MCAO mice [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 711-718. |
[10] | Jianwei Gao, Feng Ye. Curcumin inhibits inflammatory cytokine transcription via the apoptosis pathway in THP-1 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(2): 100-113. |
[11] | Kuai Yu, Ruyi Li, Yuanjun Zhu, Xiaoyan Liu, Yinye Wang. Engineering the protein targeting two pathways of cerebral ischemia reperfusion injury provides better neuroprotective effect than targeting one pathway [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(11): 760-769. |
[12] | Xu Quan, Caihong Gu, Feng Yan, Yaoyao Gao, Lin Chen, Rong Wei, Bingchun Yan, Rong Hu. Porcine placental peptides improve neuroblast proliferation and differentiation via enhancement of TrkB and BDNF levels in D-glatacose-induced mouse aging model [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(10): 739-748. |
[13] | Li Lei, Yu Chen, Simin Yang, Xiangbao Meng, Siwang Yu. A novel aza-naphthoquinone inhibits tumor growth by inducing apoptosis [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(9): 600-607. |
[14] | Yuqing Meng, Lichao Wang, Yan Li, Jinyang Song, Zhiyong Du, Chun Li, Yong Jiang, Pengfei Tu, Xiaoyu Guo. Cardioprotective effects of combination of notoginseng total saponins and safflower total flavonoids against myocardial infarction in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(2): 116-122. |
[15] | Shasha Ji, Yun Lei, Xiaotian Huang, Zhiqin Gao. Protective effects of β-dihydroagarofuran-type sesquiterpene against Aβ25-35-induced neuronal apoptosis and oxidative damage [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(8): 582-589. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||